Search Results
Results found for "Dominic R Huxley"
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
Domain Nominated for Prestigious Prix Galien USA ‘Best Startup’ Award: Pioneering GPCR-Driven Immunotherapies Intracellular Allosteric Probe Selective optogenetic inhibition of Gαq or Gαi signaling by minimal RGS domains
- PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design
Point mutations are in the C-tail of PAR4 PH-binding domain; F347 L and D349A, but not E346A, abrogate
- Effects of Small Molecule Ligands on ACKR3 Receptors
receptors, revealing a key role for the deeper binding pocket composed of residues in the transmembrane domains
- 📰 GPCR Weekly News
Research Term Of Substance Use Disorder Gabab Positive Allosteric Modulator Discovery Collaboration Domain
- 📰 GPCR Weekly News, January 30 to February 5, 2023
Multiple Potassium Channel Tetramerization Domain (KCTD) family members interact with Gβγ, with effects renewed interest’ Addex Strategic Partner Completes Enrollment In Adx71149 Epilepsy Phase 2 Study Part 1 Domain
- GPCRs Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between ...
GPCR superstructures, termed receptorsomes, both at the cell surface membrane and in the intracellular domain
- How Schild Analysis Protects Your Conclusions in GPCR Research
This Week in Premium: Sneak Peek Industry insights: Domain CMO; Pfizer–Metsera; Novo Nordisk strategy
- Irreversible Drugs, Real Control: Design for Durable Target Engagement
this week: nanomedicines targeting PAR2 for sustained analgesia; Emerging Voices in GPCR Biology; Domain
- Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor
unique allosteric signal transmission mechanisms between the Nb80-binding site and the extracellular domains
- 📰 GPCR Weekly News, April 17 to 23, 2023
Methods & Updates in GPCR Research Solvent accessibility of a GPCR transmembrane domain probed by in-membrane
- Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox
Carlsson’s takeaway: AlphaFold is a powerful starting point, but domain expertise and experimental grounding
- Interacting binding insights and conformational consequences of the differential activity of...
addition, our results suggest a previously unknown sodium-binding site located in the extracellular domain
- 📰 GPCR Weekly News, March 18 to 24, 2024
First Subject in Phase 1 Trial with HTL0033744, an EP4 Agonist for Inflammatory Bowel Disease (IBD) Domain
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
-1 'Arm's Race' Developments Five protein-design questions that still challenge AI Prix Galien USA: Domain Therapeutics Nominated for the Prestigious Best Startup Award Tectonic Therapeutic Announces Positive
- 📰 GPCR Weekly News, June 19 to 25, 2023
Reviews, GPCRs, and more 7TM domain structures of adhesion GPCRs: what's new and what's missing?
- 📰 GPCR Weekly News, April 1 to 7, 2024
Financial Resultsand Confirms Its 2024 Outlook Sosei Heptares officially changed their name to Nxera Domain
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
GPCRs posses a seven-transmembrane domain architecture, which lets them transduce extracellular signals
- 📰 GPCR Weekly News, July 17 to July 23, 2023
Domain Therapeutics announces the European Patent Office decision to grant a patent for its proprietary
- 📰 GPCR Weekly News, August 21 to 27, 2023
Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain
- 📰 GPCR Weekly News, August 14 to 20, 2023
GPCR Activation and Signaling Single-molecule analysis reveals that a glucagon-bound extracellular domain
- 📰 GPCR Weekly News, April 3 to 9, 2023
Domain Therapeutics to present three posters at AACR 2023 annual meeting.
- 📰 GPCR Weekly News, March 20 to 26, 2023
Industry News Domain Therapeutics was one of the 4 Biotech Trophy nominees at 2023 HealthTech awards.
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
interaction of GLP-1 with ECL3, which leads to a tight conformation of the receptor's transmembrane domain
- 📰 GPCR Weekly News, March 11 to 17, 2024
Molecular Insights into GPCR Function Time-resolved cryo-EM of G-protein activation by a GPCR Industry News Domain
- 📰 GPCR Weekly News, March 6 to 12, 2023
Domain Therapeutics was nominated for the Trophée de l'Innovation Technologique (Technological Innovation
- 📰 GPCR Weekly News, April 22 to 28, 2024
and Molecular Insights into GPCR Function Fungal alkaloid malbrancheamide reorients the lipid binding domain
- 📰 GPCR Weekly News, April 15 to 21, 2024
presenting at the 19th Biopharma Drug Discovery Nexus Salipro Biotech will participate in BioKorea2024 Domain
- 📰 GPCR Weekly News, December 18 to 31, 2023
Adhesion GPCRs Latrophilin, an adhesion GPCR with galactose-binding lectin domain involved in the innate
- Chemokine receptor-targeted drug discovery: progress and challenges
and are also too small to be engaged by antibodies, which can only interact with the extracellular domain
- 📰 GPCR Weekly News, December 11 to 17, 2023
tANCHOR fast and cost-effective cell-based immunization approach with focus on the receptor-binding domain









